{
  "ptid_time": "009_S_4741_2014-07-15",
  "img_path": "/data/qiuhui/data/adni/images/009_S_4741/2014-07-15/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 59,651 mm³, 98.7% above the reference mean. With a Z-score of 2.34 (99.0th percentile), this represents significant enlargement; hippocampal volume measures 4,063 mm³, 49.4% below the reference mean. With a Z-score of -4.94 (0.0th percentile), this represents profound atrophy; whole brain volume measures 1,012,550 mm³, 10.8% below the reference mean. With a Z-score of -1.52 (6.4th percentile), this represents moderate atrophy. ",
  "text_data": "Age is 63.6 years. Gender is Male. Education: 16 years. MMSE: 29.0. MoCA: 25.0. Logical Memory: 0.0. APOEε4 alleles: 0.0. Biomarker levels: Florbetapir (AV45): 1.07 SUVR (normal ). ",
  "true_diagnosis": "Diagnosis: AD.",
  "gpt_diagnosis": "**Reasoning:** The imaging data shows significant ventricular enlargement (98.7% above mean) and profound hippocampal atrophy (49.4% below mean), both strongly associated with Alzheimer's pathology. However, cognitive scores (MMSE 29, MoCA 25) remain relatively high, suggesting preserved function despite structural changes.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI)**  \n**Confidence:** **Medium** (High structural evidence of neurodegeneration, but cognitive scores are borderline normal, and AV45 amyloid PET is normal, which is atypical for typical AD progression)  \n\n*Note: The normal AV45 (amyloid PET) result reduces confidence in an Alzheimer's etiology—alternative causes of hippocampal atrophy (e.g., hippocampal sclerosis, other tauopathies) should be considered.*",
  "timestamp": "2025-07-25T22:23:34.453603"
}